MediCity
Henkilöt
1/4
Julkaisut
17/133
- Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments (2024)
- Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors : The phase I/II first-in-human MATINS trial (2023)
- Bexmarilimab plus azacitidine for high-risk myelodysplastic syndrome and relapsed or refractory acute myeloid leukaemia: results from the dose-escalation part of a multicentre, single-arm, phase 1/2 trial (2025)
- Bilateral low systolic toe pressure and toe-brachial index are associated with long-term mortality in patients with peripheral artery disease (2019)
- Blood DNA methylation and breast cancer risk: a prospective nested case–control study (2026)
Turun yliopiston Tutkimustietojärjestelmän portaali